✦ LIBER ✦

The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma

✍ Scribed by Nuriye Yıldırım Özdemir; Hüseyin Abalı; Berna Öksüzoğlu; Burçin Budakoglu; Doğan Uncu; Tunç Güler; Hatice Odabaşı; Nurullah Zengin

Book ID: 107576895
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 208 KB
Volume: 27
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-009-9268-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6527 The efficacy of modified docetaxel,

6527 The efficacy of modified docetaxel, cisplatin and 5-fluorouracil in advanced stage gastric carcinoma

✍ Yildirim, N. Ozdemir; Abali, H.; Oksuzoglu, B.; Budakoglu, B.; Uncu, D.; Guler, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

The efficacy and toxicity of modified do

The efficacy and toxicity of modified docetaxel, cisplatin and 5-fluorouracil combination therapy for 27 patients with advanced stage gastric adenocarcinoma

✍ Yigui Chen; Jianwei Yang; Xiongchao Cai; Wei Gao; Fan Chen; Hui Li 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 223 KB

Bimonthly regimen of high-dose leucovori

Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, docetaxel, and cisplatin (modified DCF) in advanced gastric adenocarcinoma

✍ Ilkay Tugba Unek, Tulay Akman, Ilhan Oztop, Olcun Umit Unal, Tarik Salman, Ugur 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 226 KB

Biweekly docetaxel, fluorouracil, leucov

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

✍ Pernot, Simon; Mitry, Emmanuel; Samalin, Emmanuelle; Dahan, Laetitia; Dalban, CÃ 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 216 KB

Continuous infusion of 5-fluorouracil an

Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma

✍ Yong-Suk Chung; Yoshito Yamashita; Tohru Inoue; Tasuku Matsuoka; Bunzo Nakata; N 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 3 views

City Uni-11 cases, for an overall response rate of 50%. Patients with good performance versity Medical School, Osaka, Japan. status (PS) (0-1) and differentiated histologic type showed higher response rates (50.0% and 63.6%, respectively) than patients with poor PS (2 or 3) and undifferenti-2 Insti

Combination of cisplatin/S-1 in the trea

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study

✍ Ajani, J.A.; Buyse, M.; Lichinitser, M.; Gorbunova, V.; Bodoky, G.; Douillard, J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 502 KB